Cysteine peptidases and their inhibitors in breast and genital cancer.

• Main Authors: Magdalena Milan, Zygmunt Grzebieniak, Dorota Zyoeko, Elżbieta Teterycz, Godwin Bwire Ekonjo, Anil Kumar Agrawal, Grzegorz Marek, Maciej Siewiński
• Format: Article
• Language: English
• Published: Via Medica 2010-11-01
• Series: Folia Histochemica et Cytobiologica
• Online Access: http://czasopisma.viamedica.pl/fhc/article/view/4197

Cysteine proteinases and their inhibitors probably play the main role in carcinogenesis and metastasis. The metastasis process need external proteolytic activities that pass several barriers which are membranous structures of the connective tissue which includes, the basement membrane of blood vessels. Activities of the proteinases are regulated by endogenous inhibitors and activators. The imbalance between cysteine proteinases and cystatins seems to be associated with an increase in metastatic potential in some tumors. It has also been reported that proteinase inhibitors, specific antibodies for these enzymes and inhibition of the urokinase receptor may prevent cancer cell invasion. Some proteinase inhibitor could serve as agents for cancer treatment.